Ramosetron hydrochloride for diarrhea-predominant irritable...

Details Ramosetron hydrochloride for diarrhea-predominant irritable... Ramosetron hydrochloride for diarrhea-predominant irritable...

A - Human Necessities

61

K

A61K 31/4184 (2006.01) C07D 403/06 (2006.01)

Patent

CA 2516433

A pharmaceutical composition for therapy of diarrhea irritable bowel syndrome in male and female patients, containing from 0.001 to 0.05 mg of ramosetron hydrochloride as a daily dose or an equivalent molar amount of ramosetron or its pharmaceutically acceptable other salt as an active ingredient.

Une composition médicale destinée aux traitements des syndromes de l'intestin irritable de type diarrhée pouvant être appliquée aux patients masculins et féminins qui contient, en tant qu'ingrédient actif, du chlorhydrate de ramosétron dans une quantité comprise entre 0,001 et 0,05 mg en termes de dose journalière ou contient, en tant qu'ingrédient actif, du ramosétron ou un sel pharmaceutiquement acceptable de celui-ci dans une quantité équimolaire à celui-ci.

Affiliated with

Also associated with

Rating

Ramosetron hydrochloride for diarrhea-predominant irritable... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ramosetron hydrochloride for diarrhea-predominant irritable..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ramosetron hydrochloride for diarrhea-predominant irritable... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1626377